Literature DB >> 17703384

Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis.

M Kerkhof1, E W Steyerberg, J G Kusters, E J Kuipers, P D Siersema.   

Abstract

BACKGROUND AND STUDY AIMS: In patients with presumed Barrett esophagus we evaluated clinical risk factors that could predict the presence of intestinal metaplasia and dysplasia in biopsies of columnar-lined esophagus (CLE), independently of histological results. PATIENTS AND METHODS: In 908 patients with CLE of length > or = 2 cm, data on age, sex, reflux symptoms, tobacco and alcohol use, medication use, and upper gastrointestinal endoscopy findings were prospectively collected. Multivariate logistic regression analysis was performed, and a model for predicting the histological results was developed.
RESULTS: In 127/908 patients, biopsies of CLE did not contain intestinal metaplasia. Of the 781 patients with intestinal metaplasia, 663 patients (85%) had no dysplasia, and 118 (15%) had low grade dysplasia (LGD). The most important predictors for the presence of intestinal metaplasia were length of CLE, size of hiatal hernia, and male sex, while among those with intestinal metaplasia, age and male sex were most important for the presence of LGD. Multivariate combinations of these predictors yielded reliable models, which were able to discriminate intestinal metaplasia well from no intestinal metaplasia (area under receiver operating characteristic [ROC] curve 0.82), but only reasonably discriminated LGD from no dysplasia (area under ROC 0.65).
CONCLUSIONS: A simple model based on clinical findings can be used to predict the presence of intestinal metaplasia in biopsies from CLE. In contrast, predicting the presence of LGD versus no dysplasia in intestinal metaplasia is more difficult. Predictions from these models may aid decision making on whether a patient with CLE should have surveillance, in view of the known sampling error at endoscopy and interobserver variability at histology.

Entities:  

Mesh:

Year:  2007        PMID: 17703384     DOI: 10.1055/s-2007-966737

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  6 in total

Review 1.  Barrett esophagus: an update.

Authors:  Rami J Badreddine; Kenneth K Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 46.802

2.  Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study.

Authors:  Zoe R Edelstein; Mary P Bronner; Sheldon N Rosen; Thomas L Vaughan
Journal:  Am J Gastroenterol       Date:  2009-03-24       Impact factor: 10.864

3.  Barrett esophagus: perspectives on its diagnosis and management in asian populations.

Authors:  Yuji Amano; Yoshikazu Kinoshita
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-01

4.  Magnification endoscopy and chromoendoscopy in evaluation of specialized intestinal metaplasia in Barrett's Esophagus.

Authors:  Justyna Wasielica-Berger; Andrzej Baniukiewicz; Eugeniusz Wroblewski; Adam Chwiesko; Andrzej Dabrowski
Journal:  Dig Dis Sci       Date:  2011-01-12       Impact factor: 3.199

5.  Proton Pump Inhibitors Diminish Barrett's Esophagus Length: Our Experience.

Authors:  Zaim Gashi; Elton Bahtiri; Arjeta Gashi; Fadil Sherifi
Journal:  Open Access Maced J Med Sci       Date:  2018-06-08

6.  A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagus.

Authors:  Michelle E Kruijshaar; Marie-Louise Essink-Bot; Bas Donkers; Caspar W N Looman; Peter D Siersema; Ewout W Steyerberg
Journal:  BMC Med Res Methodol       Date:  2009-05-19       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.